Tff Pharmaceuticals Stock Total Asset
| TFFP Stock | USD 0.34 0.03 9.68% |
Tff Pharmaceuticals fundamentals help investors to digest information that contributes to Tff Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Tff Stock. The fundamental analysis module provides a way to measure Tff Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tff Pharmaceuticals stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 12 M | 11.4 M |
Tff | Total Asset |
Tff Pharmaceuticals Company Total Asset Analysis
Tff Pharmaceuticals' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Tff Pharmaceuticals Total Asset | 12.03 M |
Most of Tff Pharmaceuticals' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tff Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Tff Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Tff Pharmaceuticals is extremely important. It helps to project a fair market value of Tff Stock properly, considering its historical fundamentals such as Total Asset. Since Tff Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tff Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tff Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Tff Net Tangible Assets
Net Tangible Assets |
|
Based on the latest financial disclosure, Tff Pharmaceuticals has a Total Asset of 12.03 M. This is 99.84% lower than that of the Pharmaceuticals sector and 99.39% lower than that of the Health Care industry. The total asset for all United States stocks is 99.96% higher than that of the company.
Tff Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tff Pharmaceuticals' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tff Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Tff Pharmaceuticals by comparing valuation metrics of similar companies.Tff Pharmaceuticals is currently under evaluation in total asset category among its peers.
Tff Pharmaceuticals Institutional Holders
Institutional Holdings refers to the ownership stake in Tff Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Tff Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Tff Pharmaceuticals' value.| Shares | Nordwand Advisors Llc | 2024-09-30 | 1000 | University Of Texas Investment Mgmt Co | 2024-09-30 | 882 | Ubs Group Ag | 2024-06-30 | 735 | Org Partners Llc | 2024-09-30 | 540 | Royal Bank Of Canada | 2024-06-30 | 156 | Raleigh Capital Management Inc. | 2024-09-30 | 91.0 | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 64.0 | Wells Fargo & Co | 2024-06-30 | 61.0 | Hm Payson & Co | 2024-09-30 | 60.0 | Carlson Capital Lp | 2024-09-30 | 293.5 K | Armistice Capital, Llc | 2024-09-30 | 228 K |
Tff Fundamentals
| Return On Equity | -2.14 | ||||
| Return On Asset | -1.06 | ||||
| Operating Margin | (6.09) % | ||||
| Current Valuation | (1.06 M) | ||||
| Shares Outstanding | 4.44 M | ||||
| Shares Owned By Insiders | 3.31 % | ||||
| Shares Owned By Institutions | 24.37 % | ||||
| Number Of Shares Shorted | 304.26 K | ||||
| Price To Book | 0.48 X | ||||
| Price To Sales | 1.25 X | ||||
| Revenue | 733.87 K | ||||
| Gross Profit | (21.21 M) | ||||
| EBITDA | (20.74 M) | ||||
| Net Income | (21.24 M) | ||||
| Cash And Equivalents | 13.15 M | ||||
| Cash Per Share | 0.51 X | ||||
| Total Debt | 115.25 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 4.04 X | ||||
| Cash Flow From Operations | (16.04 M) | ||||
| Short Ratio | 1.77 X | ||||
| Earnings Per Share | (5.50) X | ||||
| Target Price | 30.0 | ||||
| Number Of Employees | 19 | ||||
| Beta | 1.32 | ||||
| Market Capitalization | 1.5 M | ||||
| Total Asset | 12.03 M | ||||
| Retained Earnings | (118.33 M) | ||||
| Working Capital | 5.16 M | ||||
| Net Asset | 12.03 M |
About Tff Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tff Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tff Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tff Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Tff Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tff Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Tff Stock
| 0.68 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.85 | PFE | Pfizer Inc Aggressive Push | PairCorr |
Moving against Tff Stock
| 0.77 | FNMFO | Federal National Mortgage | PairCorr |
| 0.73 | AVAL | Grupo Aval | PairCorr |
| 0.68 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.54 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.52 | CIB | Bancolombia SA ADR | PairCorr |
The ability to find closely correlated positions to Tff Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tff Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tff Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tff Pharmaceuticals to buy it.
The correlation of Tff Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tff Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tff Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tff Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Tff Stock Analysis
When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.